FLIN ETF: What Is It? A Complete Guide – Returns, Expense Ratio, Holdings & Alternative ETFs
A passive ETF offering broad exposure to Indian large- and mid-cap stocks. Its key features include a below-category-average expense ratio and a capped index structure that reduces single-stock concentration.
What is this ETF?
This is an Indian equity passive ETF managed by Franklin Templeton. It holds large- and mid-cap stocks listed on the Indian stock market on a market-cap-weighted basis and tracks a capped index designed to limit concentration in any single name.
It is well suited for investors seeking long-term diversified exposure to India's economic growth. It is typically used as a core emerging-markets position for those who want to track the broader Indian market.
It is a passive (index-tracking) ETF launched by Franklin Templeton in 2017.
How does it invest?
| Item | Details |
|---|---|
| Tracking Index | FTSE India RIC Capped Index |
| Management Style | Passive (Index Tracking) |
| Rebalancing Frequency | Quarterly |
| Dividend Schedule | Semi-annual |
| Total Expense Ratio | 0.19% |
The ETF replicates or representative-samples large- and mid-cap stocks listed on the Indian exchange. Thanks to its capped structure, which limits the weight of any single name, top-holding concentration is somewhat lower than that of a pure market-cap-weighted approach. It provides diversified exposure across multiple Indian sectors, including IT, financials, and energy.
- Expense ratio is below the category average
- The capped index structure reduces concentration in top holdings
Size and costs
Assets under management (AUM) stand at $2.6B, with a total expense ratio of 0.19% annually.
The expense ratio is lower than that of INDA, the leading ETF in the same India equity category, and the two ETFs track different indices. INDA follows the MSCI India Index, while FLIN tracks a capped index of Indian large- and mid-cap stocks, so the constituents and weightings may differ.
Performance and flows
Against a backdrop of expectations for strong Indian economic growth and expanding domestic consumption, Indian equity ETFs continue to draw attention. However, rupee exchange-rate volatility and elevated Indian equity valuations can drive short-term fluctuations.
As interest in India within the emerging-markets universe rises, steady inflows into India-specific ETFs have been observed. The low expense ratio has caught the attention of long-term investors, supporting growth in assets under management.
Pros and cons
Low costs and broad diversification across the Indian market are key strengths, while emerging-markets-specific currency and policy risks are the main drawbacks.
💪 Key strengths
⚠️ Points to watch
Alternative ETFs and related products
INDA, shown in the table, is the largest India ETF and serves as the most direct comparison. While FLIN and INDA share the same country exposure, they track different indices. EWZ focuses on Brazil, EWT on Taiwan, MCHI on broad China, and FXI on Chinese large caps, all of which differ from India-focused ETFs in their country exposure but are commonly benchmarked within the emerging-markets single-country ETF category. For those seeking leveraged India exposure, INDL can be considered, and investors preferring an earnings-weighted selection approach may also want to look at EPI.
| Ticker | Name | Price | Change | AUM | Total Expense Ratio | Dividend Yield | 1Y |
|---|---|---|---|---|---|---|---|
| iShares MSCI Taiwan ETF | $110.91 | +1.8% | $11.9B | 0.59% | 0.91% | +81.9% | |
| iShares MSCI Brazil ETF | $38.19 | -1.0% | $8.8B | 0.59% | 3.55% | +27.5% | |
| iShares MSCI India ETF | $48.57 | +1.0% | $6.6B | 0.61% | - | -8.8% | |
| iShares MSCI China ETF | $52.96 | +0.3% | $6.1B | 0.59% | 2.07% | -17.5% | |
| iShares China Large-Cap ETF | $34.49 | +0.4% | $4.1B | 0.74% | 1.97% | -15.3% |
| Ticker | Name | Weight | Price | Change | Market Cap | P/E | Dividend Yield |
|---|---|---|---|---|---|---|---|
| HDB | HDFC Bank Ltd ADR | 0.06% | $23.34 | +6.9% | $119.9B | 13.8 | 1.85% |
| HDB | HDFC Bank Ltd ADR | 0.06% | $23.34 | +6.9% | $119.9B | 13.8 | 1.85% |
| IBN | ICICI Bank Ltd ADR | 0.04% | $29.39 | +1.9% | $105.5B | 17.2 | 0.96% |
| IBN | ICICI Bank Ltd ADR | 0.04% | $29.39 | +1.9% | $105.5B | 17.2 | 0.96% |
| INFY | Infosys Ltd ADR | 0.02% | $11.07 | +1.5% | $44.9B | 13.6 | 5.6% |
| INFY | Infosys Ltd ADR | 0.02% | $11.07 | +1.5% | $44.9B | 13.6 | 5.6% |
| Dr. Reddy's Laboratories Ltd ADR | 0.01% | $11.90 | +1.6% | $9.9B | 26.7 | 0.68% | |
| Dr. Reddy's Laboratories Ltd ADR | 0.01% | $11.90 | +1.6% | $9.9B | 26.7 | 0.68% | |
| GEV | GE Vernova Inc | 0.00% | $957.27 | +3.6% | $255.0B | 27.4 | 0.21% |
| Wipro Ltd ADR | 0.00% | $1.69 | +1.2% | $16.7B | 12.2 | 5.9% |
Investor checklist
Here are the key checkpoints to review before investing in FLIN. Because it is a single-country India ETF, concentration risk outweighs diversification benefits, making position sizing within the overall portfolio especially important.
| Checkpoint | What to verify | Current status |
|---|---|---|
| 💵 Expense ratio | Check cumulative costs over long-term holding | Below the category average |
| 💱 Currency impact | Impact of rupee/dollar exchange-rate swings on returns | Unhedged |
| 🌏 Emerging-markets weighting | Appropriateness of EM and India weight within the overall portfolio | Caution advised for concentrated positions |
| 📊 Index structure | Understand differences versus the MSCI India Index | Differences in constituents exist |
As a single-country India ETF, FLIN carries country-concentration risk. A weakening rupee, changes in Indian government regulations on foreign investment, or capital outflows from emerging markets can all lead to significant short-term drawdowns.
It is an efficient choice for long-term investors seeking low-cost diversified exposure to India's economic growth. Comparing the index differences with fellow India ETF INDA before making a selection is advisable.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. All investment responsibility lies with the investor.